MIVU:XETRA:XETRA-Amundi Index Solutions MSCI USA Minimum Volatility Factor UCITS (EUR)

ETF | Others |

Last Closing

USD 84.97

Change

0.00 (0.00)%

Market Cap

USD 0.30B

Volume

96.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.32 (-0.63%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.11 (-0.67%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.16 (-0.59%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.18 (-0.64%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.16 (-0.68%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-1.22 (-0.80%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

-0.23 (-0.52%)

USD 102.57B
8R80:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.04%)

USD 102.14B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.31 (-0.62%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.50 (-0.10%)

USD 80.38B

ETFs Containing MIVU:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.05% 73% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.05% 73% C 71% C-
Trailing 12 Months  
Capital Gain 15.03% 67% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.03% 66% D+ 67% D+
Trailing 5 Years  
Capital Gain 50.90% 72% C 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.90% 72% C 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 7.43% 67% D+ 65% D
Dividend Return 7.43% 66% D+ 62% D
Total Return N/A 65% D 57% F
Risk Return Profile  
Volatility (Standard Deviation) 10.35% 61% D- 69% C-
Risk Adjusted Return 71.72% 89% A- 89% A-
Market Capitalization 0.30B 57% F 51% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike